Logo image of OTRK

ONTRAK INC (OTRK) Stock Fundamental Analysis

USA - NASDAQ:OTRK - US6833734014 - Common Stock

0.3299 USD
-0.04 (-11.98%)
Last: 8/15/2025, 8:00:02 PM
0.265 USD
-0.06 (-19.67%)
After Hours: 8/15/2025, 8:00:02 PM
Fundamental Rating

1

Overall OTRK gets a fundamental rating of 1 out of 10. We evaluated OTRK against 100 industry peers in the Health Care Providers & Services industry. OTRK has a bad profitability rating. Also its financial health evaluation is rather negative. OTRK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OTRK has reported negative net income.
OTRK had a negative operating cash flow in the past year.
In the past 5 years OTRK always reported negative net income.
OTRK had a negative operating cash flow in each of the past 5 years.
OTRK Yearly Net Income VS EBIT VS OCF VS FCFOTRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of OTRK (-445.78%) is worse than 97.12% of its industry peers.
With a Return On Equity value of -1752.70%, OTRK is not doing good in the industry: 83.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -445.78%
ROE -1752.7%
ROIC N/A
ROA(3y)-265.11%
ROA(5y)-172.32%
ROE(3y)-706.96%
ROE(5y)-452.52%
ROIC(3y)N/A
ROIC(5y)N/A
OTRK Yearly ROA, ROE, ROICOTRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

With a decent Gross Margin value of 57.60%, OTRK is doing good in the industry, outperforming 78.85% of the companies in the same industry.
OTRK's Gross Margin has improved in the last couple of years.
OTRK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y8.5%
OTRK Yearly Profit, Operating, Gross MarginsOTRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

OTRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OTRK has been increased compared to 1 year ago.
The number of shares outstanding for OTRK has been increased compared to 5 years ago.
OTRK has a worse debt/assets ratio than last year.
OTRK Yearly Shares OutstandingOTRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
OTRK Yearly Total Debt VS Total AssetsOTRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

Based on the Altman-Z score of -45.00, we must say that OTRK is in the distress zone and has some risk of bankruptcy.
OTRK's Altman-Z score of -45.00 is on the low side compared to the rest of the industry. OTRK is outperformed by 93.27% of its industry peers.
OTRK has a Debt/Equity ratio of 2.05. This is a high value indicating a heavy dependency on external financing.
OTRK has a Debt to Equity ratio of 2.05. This is in the lower half of the industry: OTRK underperforms 74.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Altman-Z -45
ROIC/WACCN/A
WACC5.39%
OTRK Yearly LT Debt VS Equity VS FCFOTRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.72 indicates that OTRK may have some problems paying its short term obligations.
OTRK's Current ratio of 0.72 is on the low side compared to the rest of the industry. OTRK is outperformed by 85.58% of its industry peers.
OTRK has a Quick Ratio of 0.72. This is a bad value and indicates that OTRK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.72, OTRK is doing worse than 79.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
OTRK Yearly Current Assets VS Current LiabilitesOTRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for OTRK have decreased strongly by -61.41% in the last year.
Looking at the last year, OTRK shows a very negative growth in Revenue. The Revenue has decreased by -21.03% in the last year.
Measured over the past years, OTRK shows a very negative growth in Revenue. The Revenue has been decreasing by -20.93% on average per year.
EPS 1Y (TTM)-61.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-21.03%
Revenue growth 3Y-49.48%
Revenue growth 5Y-20.93%
Sales Q2Q%-24.74%

3.2 Future

OTRK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.54% yearly.
The Revenue is expected to grow by 65.61% on average over the next years. This is a very strong growth
EPS Next Y49.2%
EPS Next 2Y29.99%
EPS Next 3Y22.44%
EPS Next 5Y15.54%
Revenue Next Year4.96%
Revenue Next 2Y43.25%
Revenue Next 3Y56.59%
Revenue Next 5Y65.61%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OTRK Yearly Revenue VS EstimatesOTRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
OTRK Yearly EPS VS EstimatesOTRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OTRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OTRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTRK Price Earnings VS Forward Price EarningsOTRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTRK Per share dataOTRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

OTRK's earnings are expected to grow with 22.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.99%
EPS Next 3Y22.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OTRK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONTRAK INC

NASDAQ:OTRK (8/15/2025, 8:00:02 PM)

After market: 0.265 -0.06 (-19.67%)

0.3299

-0.04 (-11.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-11 2025-11-11
Inst Owners18.65%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap2.34M
Analysts82.86
Price Target3.06 (827.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.61%
Min EPS beat(2)-30.46%
Max EPS beat(2)1.23%
EPS beat(4)1
Avg EPS beat(4)-31.68%
Min EPS beat(4)-86.27%
Max EPS beat(4)1.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-20.84%
Min Revenue beat(2)-41.84%
Max Revenue beat(2)0.16%
Revenue beat(4)1
Avg Revenue beat(4)-13.1%
Min Revenue beat(4)-41.84%
Max Revenue beat(4)0.16%
Revenue beat(8)1
Avg Revenue beat(8)-24.66%
Revenue beat(12)1
Avg Revenue beat(12)-23.76%
Revenue beat(16)4
Avg Revenue beat(16)-16.46%
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)6.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.63
EYN/A
EPS(NY)-2.37
Fwd EYN/A
FCF(TTM)-1.85
FCFYN/A
OCF(TTM)-1.82
OCFYN/A
SpS1.44
BVpS0.66
TBVpS-0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -445.78%
ROE -1752.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.6%
FCFM N/A
ROA(3y)-265.11%
ROA(5y)-172.32%
ROE(3y)-706.96%
ROE(5y)-452.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y8.5%
F-Score2
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.45%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z -45
F-Score2
WACC5.39%
ROIC/WACCN/A
Cap/Depr(3y)14.24%
Cap/Depr(5y)49.22%
Cap/Sales(3y)3.95%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y49.2%
EPS Next 2Y29.99%
EPS Next 3Y22.44%
EPS Next 5Y15.54%
Revenue 1Y (TTM)-21.03%
Revenue growth 3Y-49.48%
Revenue growth 5Y-20.93%
Sales Q2Q%-24.74%
Revenue Next Year4.96%
Revenue Next 2Y43.25%
Revenue Next 3Y56.59%
Revenue Next 5Y65.61%
EBIT growth 1Y-8.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y31.42%
EBIT Next 5Y30.92%
FCF growth 1Y32.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.01%
OCF growth 3YN/A
OCF growth 5YN/A